comparemela.com

Latest Breaking News On - Christopher viehbacher - Page 8 : comparemela.com

Biogen drops controversial Alzheimer s drug, focuses on other treatments

Biogen announced plans to discontinue one of its controversial drugs, Aduhelm, and is shifting its focus on treatments that will drive long-term growth.

Biogen discontinues Aduhelm for Alzheimer s to focus on Leqembi

Biogen discontinues Aduhelm for Alzheimer s to focus on Leqembi
alzheimersnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alzheimersnewstoday.com Daily Mail and Mail on Sunday newspapers.

Biogen pulls controversial Alzheimer s drug Aduhelm

A controversial Alzheimer's drug that was trumpeted as the first to ever treat the cognitive decline associated with the devastating brain disorder has been pulled from the market, its maker Biogen announced Wednesday. It showed a reduction in cognitive decline in one of the studies, but not the other.

Biogen Pulls Controversial Alzheimer s Drug Aduhelm

A controversial Alzheimer s drug that was trumpeted as the first to ever treat the cognitive decline associated with the devastating brain disorder has been pulled from the market, its maker Biogen announced Wednesday.

Controversial Alzheimer drug pulled out from market

Controversial Alzheimer drug pulled out from market
khaleejtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from khaleejtimes.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.